Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
Advanced Micro Devices
AMD
|
+$296M |
| 3 |
Apple
AAPL
|
+$275M |
| 4 |
Qualcomm
QCOM
|
+$218M |
| 5 |
NVIDIA
NVDA
|
+$187M |
Top Sells
| 1 |
Amazon
AMZN
|
+$536M |
| 2 |
Uber
UBER
|
+$438M |
| 3 |
Chevron
CVX
|
+$280M |
| 4 |
Meta Platforms (Facebook)
META
|
+$264M |
| 5 |
CrowdStrike
CRWD
|
+$242M |
Sector Composition
| 1 | Technology | 19.65% |
| 2 | Healthcare | 18.08% |
| 3 | Consumer Discretionary | 13.75% |
| 4 | Industrials | 8.66% |
| 5 | Financials | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Inuvo
INUV
$52.3M
| $154K | ﹤0.01% |
60,100
-14,066
| -19% | -$36.1K |
|
3102
Research Frontiers
REFR
$42.7M
| $154K | ﹤0.01% |
83,800
+6,656
| +9% | +$12.2K |
|
3103
Gain Therapeutics
GANX
$61.8M
| $152K | ﹤0.01% |
118,700
+72,000
| +154% | +$92.2K |
|
3104
SES AI
SES
$424M
| $152K | ﹤0.01% |
121,300
+46,800
| +63% | +$58.5K |
|
3105
Stoke Therapeutics
STOK
$1.31B
| $151K | ﹤0.01% |
11,200
-7,900
| -41% | -$107K |
|
3106
Synlogic
SYBX
$17.2M
| $151K | ﹤0.01% |
100,530
-17,905
| -15% | -$26.9K |
|
3107
LINKBANCORP
LNKB
$271M
| $151K | ﹤0.01% |
+24,600
| New | +$151K |
|
3108
Imperial Petroleum
IMPP
$142M
| $150K | ﹤0.01% |
38,600
-31,800
| -45% | -$123K |
|
3109
Skillful Craftsman
EDTK
$17.5M
| $150K | ﹤0.01% |
142,500
+900
| +0.6% | +$945 |
|
3110
Cognition Therapeutics
CGTX
$208M
| $149K | ﹤0.01% |
89,718
-65,982
| -42% | -$110K |
|
3111
One Stop Systems
OSS
$122M
| $147K | ﹤0.01% |
61,200
+8,300
| +16% | +$20K |
|
3112
Southland Holdings
SLND
$227M
| $147K | ﹤0.01% |
32,200
+16,999
| +112% | +$77.9K |
|
|
TOUR
3113
Tuniu
TOUR
$107M
| $144K | ﹤0.01% |
172,330
| – | – |
|
3114
Gogoro
GGR
$99.5M
| $143K | ﹤0.01% |
93,100
+40,400
| +77% | +$62.2K |
|
3115
Actinium Pharmaceuticals
ATNM
$52.4M
| $142K | ﹤0.01% |
+19,200
| New | +$142K |
|
3116
Richtech Robotics
RR
$518M
| $142K | ﹤0.01% |
+108,400
| New | +$142K |
|
3117
SIFCO Industries
SIF
$44.8M
| $141K | ﹤0.01% |
45,534
-15,200
| -25% | -$47.1K |
|
3118
Daxor
DXR
$55.4M
| $141K | ﹤0.01% |
15,121
-200
| -1% | -$1.86K |
|
3119
Compass Therapeutics
CMPX
$606M
| $141K | ﹤0.01% |
140,600
+70,200
| +100% | +$70.2K |
|
3120
UNIFI
UFI
$81.9M
| $140K | ﹤0.01% |
23,800
+1,500
| +7% | +$8.84K |
|
3121
Sensei Biotherapeutics
SNSE
$11.8M
| $139K | ﹤0.01% |
11,189
+639
| +6% | +$7.93K |
|
3122
First Guaranty Bancshares
FGBI
$124M
| $138K | ﹤0.01% |
+15,315
| New | +$138K |
|
|
AHG
3123
Akso Health Group
AHG
$1.01B
| $137K | ﹤0.01% |
167,260
-39,538
| -19% | -$32.4K |
|
3124
NiSun International Enterprise Development Group
NISN
$17.4M
| $136K | ﹤0.01% |
39,095
-36,373
| -48% | -$127K |
|
3125
Surrozen
SRZN
$97.8M
| $136K | ﹤0.01% |
12,426
-1,300
| -9% | -$14.2K |
|